Cambridge, MA, United States of America

Akin Akinc

This inventor holds 62 USPTO granted patents and 64 published patent applications, plus 10 CIPO patents and 23 EPO patents, primarily in Biodegradable Lipids (CPC class C07C). Top assignees: Alnylam Pharmaceuticals, Inc., Arbutus Biopharma Corporation, Tekmira Pharmaceuticals Corporation. Active years: 2008-2026.

USPTO Granted Patents = 62 

% Patents Active = 95.2

 

 

Average Co-Inventor Count = 5.5

ph-index = 17

Forward Citations = 1,754(Granted Patents)

Forward Citations (Not Self Cited) = 1,506(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Newton, MA (US) (2008 - 2011)
  • Needham, MA (US) (2009 - 2021)
  • Cambridge, MA (US) (2011 - 2023)

Company Filing History:


Years Active: 2008-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Biodegradable Lipids
iRNA Compositions
Lipid Formulations
Active Agent Delivery
Multi-Targeted Conjugates
Nucleic Acid Formulations
PCSK9 Inhibition
Serpinc1 Disorders
Stable Formulations
Efficacy Enhancement
Kininogen
Factor XII
62 patents (USPTO):Explore Patents

Title: Akin Akinc: Pioneering Innovations in Biodegradable Lipids for Drug Delivery

Introduction:

Akin Akinc, a prolific inventor based in Cambridge, MA, has made significant contributions to the field of biodegradable lipids for the delivery of active agents. With an impressive portfolio of 52 patents, Akinc's work is reshaping the landscape of drug delivery technologies.

Latest Patents:

Among his latest patents is the groundbreaking invention of cationic lipids with biodegradable groups, enhancing the efficacy of lipid particles in delivering active agents such as nucleic acids. These innovations hold immense promise in revolutionizing the pharmaceutical industry by facilitating targeted and efficient drug delivery mechanisms.

Career Highlights:

Akinc's career showcases a remarkable journey marked by his tenure at renowned companies such as Alnylam Pharmaceuticals, Inc. and Tekmira Pharmaceuticals Corporation. His expertise and innovative prowess have been instrumental in driving forward cutting-edge research and development initiatives in the healthcare sector.

Collaborations:

Throughout his career, Akinc has collaborated with esteemed professionals in the field, including Kallanthottathil G Rajeev and Muthiah Manoharan. Together, they have synergized their expertise to push the boundaries of drug delivery technologies and pave the way for novel therapeutic solutions.

Conclusion:

In conclusion, Akin Akinc stands as a trailblazing inventor whose pioneering work in biodegradable lipids for drug delivery has the potential to transform the way we approach healthcare. With a wealth of experience and a steadfast commitment to innovation, Akinc continues to shape the future of pharmaceuticals and inspire the next generation of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…